UCL has made dementia a priority
Dementia is the greatest scientific, medical and socio-economic challenge of our times and affects more than 46 million people worldwide. As populations age, dementia is inevitably going to become more common with devastating personal, social and economic implications.
UCL can lay claim to world-leading expertise across the spectrum of research, from genetics to evidence based treatments and support for patients and carers. We have both the ambition and ability to make a difference and meet the challenge of this most pressing of global public health problems.
The UK Dementia Research Institute is a joint investment into dementia research led by the Medical Research Council alongside founding charity partners Alzheimer’s Society and Alzheimer’s Research UK. The Institute will be catalytic in the UK’s research efforts to diagnose, treat, care for and prevent dementias, a group of neurodegenerative disorders which include Alzheimer’s, Parkinson’s, Huntington’s disease and vascular dementia. The hub of the institute activity and operational headquarters is based at UCL.
The risk of developing dementia is around 3.5 times higher in frail older adults than in their non-frail peers, according to a new study from UCL.
Published: Nov 16, 2017 10:09:21 AM
More than 200 Chinese students graduated from UCL in Beijing at the weekend in the university’s first graduation ceremonies held in China.
Published: Nov 13, 2017 11:02:55 AM